about
Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm.A peptide from human β thymosin as a platform for the development of new anti-biofilm agents for Staphylococcus spp. and Pseudomonas aeruginosa.Safety and performance evaluation of a next-generation antimicrobial dressing in patients with chronic venous leg ulcers.Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activitySilver oxynitrate - an efficacious compound for the prevention and eradication of dual-species biofilms.Antimicrobial and Antibiofilm Activity of a Recombinant Fragment of β-Thymosin of Sea Urchin
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinician perceptions of wound biofilm.
@ast
Clinician perceptions of wound biofilm.
@en
type
label
Clinician perceptions of wound biofilm.
@ast
Clinician perceptions of wound biofilm.
@en
prefLabel
Clinician perceptions of wound biofilm.
@ast
Clinician perceptions of wound biofilm.
@en
P2860
P356
P1476
Clinician perceptions of wound biofilm.
@en
P2093
Daniel G Metcalf
Philip G Bowler
P2860
P304
P356
10.1111/IWJ.12358
P577
2014-09-08T00:00:00Z